Header background
adtralza_global
Adtralza® is a new treatment for adult patients with moderate-to-severe atopic dermatitis (eczema) who are candidates for systemic therapy.
adtralza-packshot

It is the first and only biologic developed to specifically neutralize IL-13, a key driver of atopic dermatitis signs and symptoms(1,2)

Learn more about how Adtralza® works and how to use it in treatment.
9out of 110
decoration image

Long term sustained improvement

9 out of 10 respondents experienced sustained disease control in clinical trials 10, providing sustained improvements in the burden of disease(1,2, 1, 8*†‡).

See efficacy and trial data
decoration image
decoration image

Long term sustained improvement

9 out of 10 respondents experienced sustained disease control in clinical trials 10, providing sustained improvements in the burden of disease(1,2, 1, 8*†‡).

Learn more about quality of life improvements
decoration image
decoration image

Long term sustained improvement

9 out of 10 respondents experienced sustained disease control in clinical trials 10, providing sustained improvements in the burden of disease(1,2, 1, 8*†‡).

See safety profile

Adtralza® neutralizes IL-13, a key driver of Atopic Dermatitis signs and symptoms.

By specifically targeting the IL-13 cytokine, Adtralza® inhibits the interaction with type II receptors and prevents IL-13-induced inflammatory responses in the skin(1,2).

Adtralza® selectively modulates the dysregulated immune system by(1):

  • Reducing markers of skin inflammation
  • Improving markers of skin barrier integrity
  • Reducing epidermal thickness
Duration 2:43

Clinical tools - at a glance

Dosing guide
Dosing guide

Adtralza® has a straightforward dosing regimen, with 150 mg prefilled syringes(1).

Learn more about application and dosing
Dosing guide
Patient injection made simple

AThis step by step video guide shows the patient how to self inject using the two syringes that come in the Adtralza® carton.

Watch the video
KOL Videos - get expert insights here

See what Key opinion leaders have to say about their experiences with Adtralza®

Video title

Short description of the contents or subject of the video. You can upload a screen from the video as thumbnail image

Video title

Short description of the contents or subject of the video. You can upload a screen from the video as thumbnail image

Video title

Short description of the contents or subject of the video. You can upload a screen from the video as thumbnail image

Video title

Short description of the contents or subject of the video. You can upload a screen from the video as thumbnail image

references

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Alias accusantium pariatur quasi. Quaerat sunt earum nihil saepe, quam obcaecati inventore adipisci nam porro dolor itaque ipsum magni, molestiae nisi suscipit?